Expanded Access to ONC201 for Patients with H3 K27M-mutant and/or Midline Gliomas
Brief description of study
This is an intermediate-size expanded access protocol to provide ONC201 to patients with H3 K27M-mutant and/or midline gliomas who cannot access ONC201 through clinical trials.
Clinical Study Identifier: s20-01692
ClinicalTrials.gov Identifier: NCT04617002
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
